Skip to main content

The independent medical news service

23-04-2021 | Oncology | News | Article

Lenvatinib–everolimus has ‘encouraging activity’ in untreated non-clear cell RCC

Previously untreated patients with advanced non-clear cell renal cell carcinoma could benefit from treatment with lenvatinib plus everolimus, suggests a phase 2 study.

16-04-2021 | Oncology | News | Article

Outliers in link between obesity and poor cancer survival reinforced in meta-analysis

Individuals with obesity tend to have worse cancer survival outcomes than those without obesity, unless they have lung cancer, renal cell carcinoma, or melanoma, show findings of a systematic review and meta-analysis.

07-04-2021 | Oncology | News | Article

Evidence for active surveillance in mRCC grows

Real-world data suggest that active surveillance may be a feasible treatment option for some patients with metastatic renal cell carcinoma.

11-03-2021 | Oncology | News | Article

Tivozanib approved for US patients with refractory advanced RCC

More information about this approval here

09-03-2021 | Oncology | News | Article

RCC obesity paradox holds true in ICI era

Researchers report an association between high BMI and improved outcomes in response to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

02-03-2021 | Oncology | News | Article

Cabozantinib–nivolumab receives EMA positive opinion for advanced RCC

Click through to read more

Image Credits